Jose Abreu

Prof. Jose Abreu

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
NANathália G. Amado
Nathália G. Amado
DPDanilo Predes
Danilo Predes
BFBarbara F. Fonseca
Barbara F. Fonseca
DCDébora M. Cerqueira
Débora M. Cerqueira
ARAlice H. Reis
Alice H. Reis
JAJose Abreu
Jose Abreu
Flavonoids are plant-derived polyphenolic molecules that have potential biological effects including antioxidative, anti-inflammatory, antiviral, and anti-tumoral. These effects are related to the ability of flavonoids to modulate signaling pathways, such as the canonical Wnt signaling pathway. This pathway controls many aspects of embryonic development and tissue maintenance and has been found to be deregulated in a range of human cancers. We performed several in vivo assays in Xenopus embryos, a functional model of canonical Wnt signaling studies, and also used in vitro models, to investigate whether isoquercitrin affects Wnt/β-catenin signaling. Our data provide strong support for an inhibitory effect of isoquercitrin on Wnt/β-catenin, where the flavonoid acts downstream of β-catenin translocation to the nuclei. Isoquercitrin affects Xenopus axis establishment, reverses double axes and the LiCl hyperdorsalization phenotype, and reduces Xnr3 expression. In addition, this flavonoid shows anti-tumoral effects on colon cancer cells (SW480, DLD-1 and HCT116), while exerting no significant effect on non-tumor colon cell (IEC-18), suggesting a specific effect in tumor cells in vitro. Taken together, our data indicate that isoquercitrin is an inhibitor of Wnt/β-catenin and should be further investigated as a potential novel anti-tumoral agent.

15 July 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GAGracielle C. de Almeida
Gracielle C. de Almeida
LOLuiz Fernando Silva Oliveira
Luiz Fernando Silva Oliveira
DPDanilo Predes
Danilo Predes
HFHarold H. Fokoue
Harold H. Fokoue
RKRicardo M. Kuster
Ricardo M. Kuster
JAJose Abreu
Jose Abreu
More than 94% of colorectal cancer cases have mutations in one or more Wnt/β-catenin signaling pathway components. Inactivating mutations in APC or activating mutations in β-catenin (CTNNB1) lead to signaling overactivation and subsequent intestinal hyperplasia. Numerous classes of medicines derived from synthetic or natural small molecules, including alkaloids, have benefited the treatment of different diseases, including cancer, Piperine is a true alkaloid, derived from lysine, responsible for the spicy taste of black pepper (Piper nigrum) and long pepper (Piper longum). Studies have shown that piperine has a wide range of pharmacological properties; however, piperine molecular mechanisms of action are still not fully understood. By using Wnt/β-catenin pathway epistasis experiment we show that piperine inhibits the canonical Wnt pathway induced by overexpression of β-catenin, β-catenin S33A or dnTCF4 VP16, while also suppressing β-catenin nuclear localization in HCT116 cell line. Additionally, piperine impairs cell proliferation and migration in HCT116, SW480 and DLD-1 colorectal tumor cell lines, while not affecting the non-tumoral cell line IEC-6. In summary, piperine inhibits the canonical Wnt signaling pathway and displays anti-cancer effects on colorectal cancer cell lines.

1 December 2017 in Cellular Signalling
Verified
Journal Article
Closed access
GTGiovane G Tortelote
Giovane G Tortelote
RRRenata R. Reis
Renata R. Reis
FMFabio de Almeida Mendes
Fabio de Almeida Mendes
JAJose Abreu
Jose Abreu

Verified
Journal Article
Open access
PDF file
NANathália G. Amado
Nathália G. Amado
DPDanilo Predes
Danilo Predes
MMMarcela M. Moreno
Marcela M. Moreno
ICIgor de Oliveira Carvalho
Igor de Oliveira Carvalho
FMFabio A. Mendes
Fabio A. Mendes
JAJose Abreu
Jose Abreu
It is now well documented that natural products have played an important role in anticancer therapy. Many studies focus on the ability of these natural compounds to modulate tumor-related signaling pathways and the relationship of these properties to an anticancer effect. According to the World Health Organization (WHO), colorectal cancer (CRC) is the third most common cancer and the fourth leading cause of cancer death among men and women. Therefore, finding strategies to fight against CRC is an emergent health problem. CRC has a strong association with deregulation of Wnt/β-catenin signaling pathway. As some types of natural compounds are capable of modulating the Wnt/β-catenin signaling, one important question is whether they could counteract CRC. In this review, we discuss the role of flavonoids, a class of natural compounds, on Wnt/β-catenin regulation and its possible potential for therapeutic usage on colorectal cancer.

12 July 2014 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
DADiego Pinheiro Aguiar
Diego Pinheiro Aguiar
GFGabriel Correa de Farias
Gabriel Correa de Farias
ESEduardo Branco de Sousa
Eduardo Branco de Sousa
JCJuliana de Mattos Coelho-Aguiar
Juliana de Mattos Coelho-Aguiar
JLJulie Calixto Lobo
Julie Calixto Lobo
JAJose Abreu
Jose Abreu
Connective tissue growth factor (CTGF)/CCN family member 2 (CCN2) is a CCN family member of matricellular signaling modulators. It has been shown that CCN2/CTGF mediates cell adhesion, aggregation and migration in a large variety of cell types, including vascular endothelial cells, fibroblasts, epithelial cells, aortic smooth muscle and also pluripotent stem cells. Others matricellular proteins are capable of interacting with CCN2/CTGF to mediate its function. Cell migration is a key feature for tumor cell invasion and metastasis. CCN2/CTGF seems to be a prognostic marker for cancer. In addition, here we intend to discuss recent discoveries and a new strategy to develop therapies against CCN2/CTGF, in order to treat cancer metastasis.

16 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BFBarbara F. Fonseca
Barbara F. Fonseca
DPDanilo Predes
Danilo Predes
DCDebora M. Cerqueira
Debora M. Cerqueira
ARAlice H. Reis
Alice H. Reis
NANathalia G. Amado
Nathalia G. Amado
JAJose Abreu
Jose Abreu
Overactivation of the Wnt/β-catenin pathway in adult tissues has been implicated in many diseases, such as colorectal cancer. Finding chemical substances that can prevent this phenomenon is an emerging problem. Recently, several natural compounds have been described as Wnt/β-catenin inhibitors and might be promising agents for the control of carcinogenesis. Here, we describe two natural substances, derricin and derricidin, belonging to the chalcone subclass, that show potent transcriptional inhibition of the Wnt/β-catenin pathway. Both chalcones are able to affect the cell distribution of β-catenin, and inhibit Wnt-specific reporter activity in HCT116 cells and in Xenopus embryos. Derricin and derricidin also strongly inhibited canonical Wnt activity in vitro, and rescued the Wnt-induced double axis phenotype in Xenopus embryos. As a consequence of Wnt/β-catenin inhibition, derricin and derricidin treatments reduce cell viability and lead to cell cycle arrest in colorectal cancer cell lines. Taken together, our results strongly support these chalcones as novel negative modulators of the Wnt/β-catenin pathway and colon cancer cell growth in vitro.